Norges Bank Sorrento Therapeutics, Inc. Transaction History

Norges Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	N/A	-2,901,483 Closed	0 $0
Q2 2023 Aug 14, 2023	SELL	$0.0 - $0.38 $0 - $1.1 Million	-2,901,483 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $2.31 Million - $5.72 Million	3,125,259 New	3,125,259 $2.78 Million
Q3 2022 Nov 13, 2023	BUY	$1.51 - $2.88 $4.38 Million - $8.36 Million	2,901,483 New	2,901,483 $4.56 Million
Q2 2022 Aug 14, 2023	BUY	$1.24 - $2.33 $3.6 Million - $6.76 Million	2,901,483 New	2,901,483 $5.83 Million

Q1 2022 May 12, 2023	SELL	$2.0 - $4.9 $1.88 Million - $4.61 Million	-941,676 Reduced 30.13%	2,183,583 $5.09 Million
Q1 2022 May 09, 2022	SELL	$2.0 - $4.9 $1.86 Million - $4.55 Million	-928,292 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$4.65 - $7.23 $4.32 Million - $6.71 Million	928,292 New	928,292 $4.32 Million
Q3 2021 Nov 14, 2022	BUY	$7.41 - $10.99 $5.28 Million - $7.83 Million	712,535 New	712,535 $5.44 Million

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.